Agios Pharmaceuticals reported $1.18B in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Agios Pharmaceuticals AGIO:US USD 1.18B 72.15M
Alnylam Pharmaceuticals ALNY:US USD 3.54B 204.84M
Amgen AMGN:US USD 63.7B 4.41B
Arrowhead Research ARWR:US USD 691.94M 59.84M
Astellas Pharma 4503:JP JPY 2.58T 101.82B
AstraZeneca AZN:LN USD 94.18B 2.39B
Bayer BAYN:GR EUR 131.01B 2.22B
Biogen BIIB:US USD 24.85B 227.2M
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Daiichi Sankyo 4568:JP JPY 2.43T 133.23B
Eli Lilly And LLY:US USD 47.46B 397.9M
Exelixis EXEL:US USD 2.96B 79.97M
Gilead Sciences GILD:US USD 62.56B 313M
GlaxoSmithKline GSK:LN GBP 60.31B 28.73B
Immunogen IMGN:US USD 358.8M 63.5M
IONIS PHARMACEUT IONS:US USD 2.42B 34.16M
JAZZ PHA JAZZ:US USD 10.38B 815.47M
Mirati Therapeutics MRTX:US USD 1.3B 23.29M
Moderna Inc MRNA:US USD 26.06B 13M
Nektar Therapeutics NKTR:US USD 781.01M 80.98M
Novartis NVS:US USD 118.46B 4.45B
Novartis NOVN:VX USD 118.46B 4.45B
Puma Biotechnology PBYI:US USD 198.77M 5.12M
Regeneron Pharmaceuticals REGN:US USD 27.68B 472M
Sarepta Therapeutics SRPT:US USD 3.16B 159.3M
Seattle Genetics SGEN:US USD 3.62B 11.26M
Vertex Pharmaceuticals VRTX:US USD 16.71B 1.12B
YTE INCY:US USD 5.51B 191.18M